Gene Synthesis growing at a CAGR of 16.8% from 2025 to 2033
The global gene synthesis (research-use) market size was estimated at USD 2.09 billion in 2024 and is projected to reach USD 8.39 billion by 2033, growing at a CAGR of 16.8% from 2025 to 2033. The surging investment by players in the synthetic biology field and supportive government laws & rules are expected to propel market growth.
Key Market Trends & Insights
- North America gene synthesis (research-use) market held the largest share of 36.80% of the global market in 2024.
- The gene synthesis (research-use) industry in the U.S. is expected to grow significantly over the forecast period.
- By method, the PCR-based g segment held the largest market share in 2024.
- By services, the antibody DNA synthesis segment dominated with the market share of 61.48% in 2024.
- By application, the gene & cell therapy development segment held the largest market share of 58.27% in 2024.
Market Size & Forecast
- 2024 Market Size: USD 2.09 Billion
- 2033 Projected Market Size: USD 8.39 Billion
- CAGR (2025-2033): 16.8%
- North America: Largest market in 2024
- Asia Pacific: Fastest growing market
Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/gene-synthesis-research-use-market-report/request/rs1%5D
Moreover, technological advances in gene synthesis procedures & techniques are also boosting the service demand over the forecast period. For instance, in April 2022, GenScript, a provider of life science research tools and services, announced the launch of the most advanced semiconductor chip for DNA synthesis in the field. This chip provides the highest throughput.
Technological Advancements Driving Faster and Cost-Efficient Gene Synthesis
Advancements in synthetic biology technologies are significantly transforming the gene synthesis (research-use) landscape, enabling faster, more accurate, and cost-efficient DNA synthesis processes. Continuous improvements in automation, error correction, and next-generation sequencing (NGS) integration have enhanced the precision and scalability of synthetic gene construction. These developments have substantially reduced turnaround times, allowing researchers to design and synthesize complex gene sequences within shorter timeframes. Moreover, the integration of AI-driven design tools and cloud-based bioinformatics platforms has streamlined workflow efficiency, further accelerated research timelines and reducing costs associated with manual interventions.
Market Concentration & Characteristics
The gene synthesis (research-use) industry exhibits a high level of innovation, driven by continuous advancements in automation, AI-assisted gene design, and error-correction technologies. Ongoing R&D efforts aimed at improving synthesis accuracy, scalability, and turnaround time are further enhancing the industry’s capability to support cutting-edge research in genomics, synthetic biology, and precision medicine.
The gene synthesis (research-use) industry reflects moderate M&A activities, primarily driven by companies seeking to expand their technological capabilities, global footprint, and service portfolios. Strategic acquisitions are focused on integrating advanced synthesis platforms, strengthening bioinformatics expertise, and enhancing end-to-end research solutions to meet growing demand across biotechnology, pharmaceutical, and academic research sectors.
Gene Synthesis (Research-Use) Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 2.42 billion |
|
Revenue forecast in 2033 |
USD 8.39 billion |
|
Growth rate |
CAGR of 16.8% from 2025 to 2033 |
|
Historical data |
2021 – 2024 |
|
Forecast period |
2025 – 2033 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2033 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Method, service, application, research phase, end use, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
GenScript; Azenta, Inc. (GENEWIZ); Boster Biological Technology; Twist Bioscience; ProteoGenix, Inc; Biomatik; ProMab Biotechnologies, Inc.; Thermo Fisher Scientific, Inc.; Integrated DNA Technologies, Inc. (Danaher); OriGene Technologies, Inc. |
|
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |